Disclaimer:All content on this platform is sourced from the internet and is provided for informational purposes only. None of the content represents the views of this site, nor does it constitute investment advice. Please exercise caution when investing.

Faster global financial news!

Veradermics, Incorporated

MANE NYSEHealthcare ★★★★★
Market Cap $5.47B
Latest Earnings FY2026 Q3 Above forecast↑
Date
Nov 10, 2026
ET
EPS Est.
-0.56
EPS Actual
-0.50
Revenue Est.
--
Revenue Actual
--
The next earnings date has not been announced yet; it is usually confirmed within weeks after the fiscal quarter ends.
Company Overview
Veradermics, Incorporated (ticker MANE) is listed on NYSE with a market cap of about $5.47B. In the last 4 reported quarters, EPS beat consensus estimates 3 times.
Actual EPS TrendRecently5Term · Dec 3, 2025 → FY2026 Q3
Dec 3, 2025Range: -1.63 ~ -0.50FY2026 Q3
Earnings History
Date Fiscal Period EPS Est. EPS Actual Revenue Est. Revenue Actual
Nov 10, 2026 FY2026 Q3 -0.56 Above forecast↑-0.50 -- --
Aug 11, 2026 -- -0.65 Above forecast↑-0.58 -- --
May 12, 2026 -- -0.56 Below forecast↓-1.32 -- --
Feb 25, 2026 -- -1.81 Above forecast↑-1.63 -- --
Dec 3, 2025 -- -- -1.63 -- --
Original Filings (SEC)
Links point to the company's original filings on the U.S. Securities and Exchange Commission (SEC) website. For some foreign private issuers (ADRs), the earnings filing is typically submitted to the SEC several days after the results are announced; it will appear here automatically once filed.
Report dates are US trading days (Eastern Time); EPS and revenue estimates are market consensus, in USD. This page is for reference only and does not constitute investment advice.
Current Location: Home > Economic Calendar > Earnings Calendar > MANE